IUPAC name
1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine
SMILES
CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1
Compound class
Adrenergic alpha-1 Receptor Antagonists; Antimydriatic Agents; Ophthalmics; Ophthalmologicals; Sensory Organs; Antiglaucoma Preparations and Miotics;
Therapeutic area
Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.
Common name
Dapiprazole
IUPAC name
1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine
SMILES
CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1
INCHI
InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3
FORMULA
C19H27N5
Common name
Dapiprazole
IUPAC name
1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine
Molecular weight
325.451
clogP
2.513
clogS
-4.013
HBond Acceptor
4
HBond Donor
0
Total Polar
Surface Area
37.19
Number of Rings
4
Rotatable Bond
4
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00023 | toluene |
|
c1(ccccc1)C | 0.1268 |
| FDBF00674 | 1-(o-tolyl)piperazine |
|
N1CCN(CC1)c2c(cccc2)C | 0.0003 |
| FDBF00675 | 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine |
|
n12c(nnc1C)CCCC2 | 0.0003 |
| FDBF00676 | 1-methyl-4-(o-tolyl)piperazine |
|
N1(CCN(CC1)c2c(cccc2)C)C | 0.0003 |
| FDBF00677 | 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine |
|
n12c(nnc1CC)CCCC2 | 0.0003 |
| FDBF00678 | 1-ethyl-4-(o-tolyl)piperazine |
|
N1(CCN(CC1)c2c(cccc2)C)CC | 0.0003 |
| FDBF00680 | 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine |
|
n12c(nnc1)CCCC2 | 0.0003 |
